Smart Glucose Meter Project

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Currently, in the U.S., 1 in 3 males and 2 in 5 females born after 2000 are expected to develop diabetes during his or her lifetime. Research has demonstrated that control of blood glucose (BG) reduces the complications of diabetes. As a result, almost half of Americans diagnosed with diabetes, are prescribed finger-stick glucose meters to monitor their BG. The value of this approach is known to be limited by a high rate of patient non-compliance with BG testing, where patients test less often than prescribed. Increased communication between patient and care manager along with feedback has been shown to increase self monitoring of blood glucose (SMBG) test compliance. However, this feedback loop is largely absent from the current, episodic model of patient / care manager interaction and not available in existing BG meters given to diabetic patients.

In this study, we propose to pilot test a cellular-embedded glucose meter. This device can transmit glucose readings directly over a cellular network to a care management server and then the patient will receive feedback on the screen of the glucose meter.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CGM/Clarity Use, Glycemic Control and Clinical Outcomes

NCT03827434

Diabetes Mellitus Hyperglycemia Hypoglycemia

WITHDRAWN NA

Continuous Glucose Monitoring in Prediabetes

NCT06472297

Pre-diabetes

COMPLETED NA

Assessment of Glucose Concentrations in People Without Diabetes Mellitus After Standardized Meals and in Daily Life

NCT03405415

Subjects Without Diabetes Mellitus Assessment of Glucose Concentrations

COMPLETED NA

Examining The Role of CGM in T2DM

NCT01614262

DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)

COMPLETED NA

Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device

NCT01508065

Diabetes Mellitus Type 1

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research program will enroll participants in a 6-month pilot intervention study. In this study, 100 patients with diabetes (Type 1 and Type 2) who are known to be non-compliant with SMBG will be enrolled and randomized to treatment groups (one group will receive a standard glucose meter and the second group will receive the cellular-embedded device) in order to achieve the following specific study aims;

Primary Aim 1: Determine if connecting diabetic patients to care managers via a cellular-enabled glucose meter with feedback will improve SMBG testing compliance.

Secondary Aim 2: Determine if increased testing compliance leads to improvement in overall blood glucose control. This will be measured by a reduction of HbA1c levels.

Secondary Aim 3: Determine whether this intervention leads to significant improvements in patient satisfaction with self-care and patient self-assessment of compliance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Provider-driven care, based in office, no special diabetes management; Patient self-monitoring of blood glucose (SMBG)

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

Home diabetes monitoring by patient using cellular enabled glucometer to communicate information and receive feedback.

Care provider can access raw and analyzed patient data; Physician receives report summary.

Group Type ACTIVE_COMPARATOR

Telcare Blood Glucose Meter (BGM)

Intervention Type DEVICE

Cellular enabled glucometer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telcare Blood Glucose Meter (BGM)

Cellular enabled glucometer

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age and older
* Diagnosis of Diabetes Mellitus (Type 1 or Type 2)
* Currently, non-compliant with prescribed glucose testing regimen
* HbA1c of 7.5 or greater within the last six months

Exclusion Criteria

* Actively being treated for substance abuse
* Treatment for a thought disorder within the past year
* Non-English speaking
* Persons who are legally blind
* Women who are pregnant
* Cognitively or decisionally impaired as determined by practitioner
* Persons using an insulin pump

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No